RhumbLine Advisers
TNYA icon

RhumbLine Advisers’s Tenaya Therapeutics TNYA Stock Holding History

RhumbLine Advisers’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,193
Closed -$39.4K – 4262
2025
Q1 		$39.4K Sell
69,193
-11,493
-14% -$11.3K ﹤0.01% 3625
2024
Q4 		$115K Buy
80,686
+1,087
+1% +$2.44K ﹤0.01% 3437
2024
Q3 		$154K Buy
79,599
+1,439
+2% +$4.06K ﹤0.01% 3352
2024
Q2 		$242K Buy
78,160
+7,441
+11% +$30.7K ﹤0.01% 3119
2024
Q1 		$370K Buy
70,719
+2,233
+3% +$10.7K ﹤0.01% 2846
2023
Q4 		$222K Buy
68,486
+476
+0.7% +$1.03K ﹤0.01% 3129
2023
Q3 		$173K Hold
68,010
– – ﹤0.01% 3233
2023
Q2 		$399K Buy
68,010
+3,038
+5% +$17.7K ﹤0.01% 2835
2023
Q1 		$185K Buy
64,972
+22,509
+53% +$63.3K ﹤0.01% 2753
2022
Q4 		$85K Buy
42,463
+141
+0.3% +$344 ﹤0.01% 2916
2022
Q3 		$123K Buy
42,322
+2,307
+6% +$10.8K ﹤0.01% 2981
2022
Q2 		$225K Buy
40,015
+17,217
+76% +$139K ﹤0.01% 2890
2022
Q1 		$269K Buy
22,798
+12,646
+125% +$153K ﹤0.01% 2676
2021
Q4 		$192K Sell
10,152
-70
-0.7% -$1.52K ﹤0.01% 2843
2021
Q3 		$211K Buy
+10,222
New +$220K ﹤0.01% 2898

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

RhumbLine Advisers's TNYA Position: Q2 2025 in Review

RhumbLine Advisers sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 69,193 shares — an estimated $39.4K sold.

RhumbLine Advisers first reported a position in TNYA in Q3 2021 and held it in 15 quarters. The position peaked at $399K in Q2 2023. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • RhumbLine Advisers reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 69,193 Tenaya Therapeutics shares in Q2 2025, an estimated $39.4K.
  • RhumbLine Advisers first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 15 quarters.
  • RhumbLine Advisers's Tenaya Therapeutics position peaked at $399K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.